MYELOPROLIFERATIVE NEOPLASMS
Clinical trials for MYELOPROLIFERATIVE NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE NEOPLASMS trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tailored transplants for seniors: can a simple assessment improve outcomes?
Disease control OngoingThis study looks at whether a geriatric assessment—checking thinking, mobility, mood, and nutrition—can help doctors choose the best transplant approach for people aged 60 and older with certain blood cancers. The goal is to lower the risk of serious side effects and improve qual…
Matched conditions: MYELOPROLIFERATIVE NEOPLASMS
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 07:59 UTC
-
New combo therapy targets relapsed blood cancers after transplant
Disease control OngoingThis early-phase study tests a new treatment for people whose blood cancer (like AML or MDS) has returned after a donor stem cell transplant. The treatment combines a special type of donor immune cell infusion with an immunotherapy drug called ipilimumab. The main goal is to find…
Matched conditions: MYELOPROLIFERATIVE NEOPLASMS
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 13, 2026 16:02 UTC